The Bundibugyo ebolavirus is causing a health emergency in Africa, with no current vaccines to stop it. The Serum Institute of India is teaming up with global experts to produce a new, safe vaccine candidate. This initiative offers communities a lifesaving, affordable way to protect themselves. By taking on this urgent project, the Serum Institute of India reinforces its reputation as a world leader in manufacturing essential vaccines when they are needed most.
